HIV Medicine Association

04/18/2026

Today marks National Transgender HIV Testing Day, a day to recognize the importance of routine HIV testing, status awareness, and continued focus on HIV prevention and treatment efforts among transgender and gender non-binary people.

Learn more: https://bit.ly/4tIhcLM

04/18/2026

JID is seeking proposals for papers focused on the use of long-acting antiretroviral therapies that explore new and innovative approaches to HIV care.

Learn more and submit your proposal by May 24: https://bit.ly/4ckQMZr

04/16/2026

New survey results from the Emergency HIV Clinical Task Force provide a stark look at the human impact of recent funding cuts and policy changes affecting HIV care.

Read the results: https://bit.ly/4tTU7WA

04/15/2026

Biktarvy is on the list of 15 drugs that will be subject to Medicare price negotiations taking effect in 2028. To help inform the price negotiation process, the Centers for Medicare and Medicaid Services is hosting a town hall next Wednesday, April 22 at 10:30am-12pm ET, featuring HIVMA Board member Joseph Cherabie, MD, MSc.

Learn more: https://go.cms.gov/48MGHmU

As part of the Medicare Drug Price Negotiation Program,

04/15/2026

DYK? Anyone having s*x can get an STI. This STI Awareness Week, know your STI care options and Get Yourself Tested! https://bit.ly/4dTyyh7

04/13/2026

Updated guidelines! The Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission has updated the Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States guidelines sections to address new data and publications where relevant.

Learn more:

04/10/2026

Today marks National Youth HIV & AIDS Awareness Day, a day to take action regarding the impact of HIV/AIDS on young people and to highlight the HIV prevention, treatment, and care campaigns of young people in the U.S.

Learn more: https://bit.ly/4snaCsP

04/09/2026

The Edward H. Kass Lecture is now available to the public! Watch HIVMA Past Chair Judith Feinberg, MD, FIDSA, reflect on early AIDS treatments and review key treatments and effective prophylaxis interventions from early clinical research in HIV: https://bit.ly/41t23lo

04/08/2026

Why HIV? HIVMA members share what inspired them to enter the field and what continues to motivate their work today.

Learn more about a career in HIV: www.hivma.org

04/07/2026

The President’s proposal to slash HIV public health programs is a dangerous one at a time when states are already making unprecedented cuts to HIV services due to rising costs.

Decimating the HIV prevention program that funds HIV surveillance and testing in every state would put lives at risk and leave communities more vulnerable to HIV outbreaks.

We urge Congress to prioritize the health of all Americans by rejecting these cuts and those proposed to the Ryan White HIV/AIDS Program and the National Institutes of Health. Our country deserves better.

— Anna K. Person, MD, FIDSA — Chair, HIVMA

04/02/2026

A record 130 congressional members signed a letter to the House Labor-HHS Appropriations Subcommittee requesting increased funding for domestic HIV prevention, treatment and research.

Read the letter: https://bit.ly/3PLHLRv

04/01/2026

Florida update: Gov. Ron DeSantis signed HB 697 providing $30 million for FL ADAP through June, helping 11,000+ people with HIV regain access to HIV treatment. But it’s only temporary. Key meds and premium help are still missing.

📢 Urge lawmakers to fully restore FL ADAP. Learn more: https://bit.ly/3NZJthF

Florida Governor Ron DeSantis signed a bill, HB 697, on March 24 restoring funding through June 30 to the state’s AIDS Drug Assistance Program (ADAP), returning aid eligibility for more than 11,000 recipients. The emergency law partially restores healthcare for Floridians with HIV who were thrown ...